We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RIO:LSERio Tinto plc Analysis

Data as of 2026-03-09 - not real-time

£6,635.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Technical snapshot: Rio Tinto trades at £6,635, comfortably above the computed support of £6,197 but below the 20‑day SMA of £7,146 and the 50‑day SMA of £6,738. The 30‑day volatility sits at a high 34.4% while beta is modest at 0.30, indicating a stock that moves sharply but is less correlated with broader markets. RSI is around 39, hinting at near‑oversold conditions, and the MACD shows a bearish histogram, suggesting short‑term downside pressure despite the overall bullish trend flag.
Fundamental backdrop & news catalyst: The company posted 14.6% revenue growth, solid margins (gross 28%, operating 25%) and a healthy dividend yield of 4.43% with a payout ratio near 60%. The DCF fair‑value estimate of £4,596 places the current price modestly above intrinsic value, yielding a modest upside of about 4.5%. Recent material news – the collapse of the Glencore merger talks and a new desalination joint venture in Western Australia – removes merger‑related uncertainty while underscoring operational resilience. Combined with an “Extreme Greed” market sentiment (fear‑greed index 75.9), the stock presents a balanced risk‑reward profile for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating near‑term downside
  • RSI near oversold levels offering potential bounce
  • Support at £6,197 limiting immediate downside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and solid operating margins
  • Attractive dividend yield with sustainable payout
  • Bullish technical trend despite short‑term MACD signal

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Fundamental exposure to long‑term metal demand
  • Stable cash generation and dividend consistency
  • High price‑to‑book ratio and cyclical sector dynamics

Key Metrics & Analysis

Financial Health

Revenue Growth14.60%
Profit Margin17.29%
P/E Ratio14.6
ROE16.40%
ROA7.86%
Debt/Equity35.43
P/B Ratio230.5
Op. Cash Flow£16.8B
Free Cash Flow£3.5B

Technical Analysis

TrendBullish
RSI39.4
Support£6,197.00
Resistance£7,557.00
MA 20£7,146.10
MA 50£6,738.00
MA 200£5,316.03
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Fair Value£4,596.08
Target Price£6,930.30
Upside/Downside4.45%
GradeFair
TypeBlend
Dividend Yield4.43%

Risk Assessment

Beta0.30
Volatility34.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.